INTEGRAL AD SCIENCE HOLDING CORP. [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19
	10-K	10-K	10-K	10-K
Revenues:
United States	264.2	188.6	142.1	131.0
Other	144.2	134.9	98.5	82.5
Total revenues	408.3	323.5	240.6	213.5
Revenue growth [+]	26.2%	34.4%	12.7%
United States	40.0%	32.7%	8.5%
Cost of goods sold	80.5	55.2	41.1	33.1
Gross profit	327.8	268.3	199.5	180.4
Gross margin	80.3%	82.9%	82.9%	84.5%
Selling, general and administrative [+]	185.9	165.4	98.7	103.4
Sales and marketing	106.3	86.4	65.8	71.3
General and administrative	79.7	79.0	32.9	32.1
Research and development	76.4	67.0	49.0	40.4
EBITDA [+]	65.6	35.9	51.8	36.5
EBITDA growth	82.7%	-30.8%	41.8%
EBITDA margin	16.1%	11.1%	21.5%	17.1%
Depreciation	10.5	9.7	7.6	6.1
EBITA	55.0	26.2	44.2	30.4
EBITA margin	13.5%	8.1%	18.4%	14.3%
Amortization of intangibles	39.9	52.6	58.1	64.2
EBIT [+]	15.2	-26.4	-13.9	-33.8
EBIT growth	-157.4%	90.3%	-58.9%
EBIT margin	3.7%	-8.2%	-5.8%	-15.8%
Non-recurring items [+]		6.6
Business exit costs		6.6
Interest expense	9.1	19.2	31.6	33.0
Interest expense	9.1	19.2	31.6	33.0
Other income (expense), net [+]	7.0	-3.7
Gain (loss) on debt retirement		-3.7
Gain (loss) on foreign currency transactions	4.7	0.6	0.6
Pre-tax income	13.1	-56.0	-45.5	-66.8
Income taxes	2.3	3.5	13.1	15.4
Tax rate	17.5%
Net income	13.1	-56.0	-45.5	-66.8
Net margin	3.2%	-17.3%	-18.9%	-31.3%

Basic EPS [+]	$0.08	($0.39)	($0.34)	($0.51)
Growth	-121.7%	15.0%	-33.2%
Diluted EPS [+]	$0.08	($0.39)	($0.34)	($0.51)
Growth	-121.3%	15.0%	-33.2%

Shares outstanding (basic) [+]	154.7	143.5	134.0	131.6
Growth	7.8%	7.1%	1.9%
Shares outstanding (diluted) [+]	157.3	143.5	134.0	131.6
Growth	9.6%	7.1%	1.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.